Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Active Ingredients: Dosage Form: New Zealand Sponsor: Manufacturer:	Apo-Alendronate Plus D3 Alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg Colecalciferol 70mcg Tablet Apotex NZ Limited Apotex Inc, Weston, Canada
Product: Active Ingredients: Dosage Form: New Zealand Sponsor: Manufacturer:	Apo-Alendronate Plus D3 Alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg Colecalciferol 140mcg Tablet Apotex NZ Limited Apotex Inc, Weston, Canada
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Dulcolax SP Drops Sodium picosulfate monohydrate 7.5mg/mL Oral solution Sanofi-Aventis New Zealand Limited Istituto de Angeli SrL, Florence, Italy
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Freeway Anti-inflammatory Throat spray Benzydamine hydrochloride 1.5mg/mL Oral spray Douglas Pharmaceuticals Limited Douglas Manufacturing Limited, Auckland, New Zealand
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Freeway Double Strength Anti-inflammatory Throat spray Benzydamine hydrochloride 3mg/mL Oral spray Douglas Pharmaceuticals Limited Douglas Manufacturing Limited, Auckland, New Zealand
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	JAQINUS Tofacitinib citrate 8.078mg equivalent to tofacitinib 5mg Film coated tablet Pfizer New Zealand Limited Pfizer Manufacturing Deutschland GmbH, Freiburg, Germany

Dated this 21st day of August 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Issue Number